IRIS UniCatt

Laterza, Lucrezia
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.291
AS - Asia 2.841
EU - Europa 2.680
SA - Sud America 623
AF - Africa 79
OC - Oceania 15
Continente sconosciuto - Info sul continente non disponibili 4
Totale 9.533
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.168
SG - Singapore 1.331
DE - Germania 622
CN - Cina 613
IT - Italia 532
BR - Brasile 508
SE - Svezia 353
FR - Francia 272
VN - Vietnam 271
PL - Polonia 201
GB - Regno Unito 148
FI - Finlandia 120
IN - India 110
UA - Ucraina 108
IE - Irlanda 94
ID - Indonesia 88
JP - Giappone 81
HK - Hong Kong 71
CA - Canada 58
AR - Argentina 49
RU - Federazione Russa 47
BD - Bangladesh 44
KR - Corea 42
TR - Turchia 41
MX - Messico 37
NL - Olanda 37
IQ - Iraq 33
ES - Italia 27
BE - Belgio 23
ZA - Sudafrica 23
AT - Austria 20
AU - Australia 13
EC - Ecuador 13
IR - Iran 13
SA - Arabia Saudita 13
VE - Venezuela 13
PK - Pakistan 12
CZ - Repubblica Ceca 11
RO - Romania 11
CL - Cile 10
CO - Colombia 10
PH - Filippine 10
LT - Lituania 9
JM - Giamaica 8
JO - Giordania 8
PY - Paraguay 8
UZ - Uzbekistan 8
BB - Barbados 7
CI - Costa d'Avorio 7
DZ - Algeria 7
EG - Egitto 7
KZ - Kazakistan 7
MA - Marocco 7
TN - Tunisia 7
AZ - Azerbaigian 6
KE - Kenya 6
PT - Portogallo 6
AE - Emirati Arabi Uniti 5
CH - Svizzera 5
HU - Ungheria 5
MY - Malesia 5
BG - Bulgaria 4
BO - Bolivia 4
ET - Etiopia 4
HR - Croazia 4
IL - Israele 4
LV - Lettonia 4
OM - Oman 4
UY - Uruguay 4
AL - Albania 3
CD - Congo 3
DO - Repubblica Dominicana 3
EU - Europa 3
LB - Libano 3
PE - Perù 3
AO - Angola 2
BH - Bahrain 2
BY - Bielorussia 2
KG - Kirghizistan 2
KW - Kuwait 2
MD - Moldavia 2
MM - Myanmar 2
NI - Nicaragua 2
NP - Nepal 2
PA - Panama 2
RS - Serbia 2
YE - Yemen 2
BA - Bosnia-Erzegovina 1
BN - Brunei Darussalam 1
CR - Costa Rica 1
CY - Cipro 1
DK - Danimarca 1
DM - Dominica 1
EE - Estonia 1
GA - Gabon 1
GH - Ghana 1
GR - Grecia 1
GT - Guatemala 1
GY - Guiana 1
HN - Honduras 1
Totale 9.516
Salva come PNG Salva come JPEG
Città #
Singapore 769
San Jose 381
Ashburn 342
Chandler 336
Warsaw 172
Beijing 121
New York 113
Rome 112
Los Angeles 111
Hefei 100
Ho Chi Minh City 92
Dublin 91
Lauterbourg 79
Milan 75
Tokyo 74
Frankfurt am Main 73
Hanoi 73
Jakarta 73
Munich 71
Jacksonville 69
Ann Arbor 68
Council Bluffs 66
Dallas 65
Hong Kong 64
Helsinki 63
San Mateo 62
São Paulo 62
The Dalles 60
Cattolica 54
Boston 46
Wilmington 40
Seoul 39
Nanjing 37
Buffalo 33
Houston 33
Woodbridge 30
Kent 29
Moscow 28
Boardman 27
Dearborn 27
St Louis 27
Fairfield 25
Marseille 25
North Bergen 25
Santa Clara 25
Nuremberg 24
Nürnberg 24
Chicago 23
Orem 23
Hyderabad 22
Lawrence 22
Seattle 22
Brooklyn 21
Brussels 20
London 20
Paris 20
Turku 19
Montreal 18
Princeton 18
Stockholm 18
Chennai 17
Denver 17
Izmir 17
Tianjin 17
Haiphong 16
Lappeenranta 16
Poplar 16
Baghdad 15
Düsseldorf 15
Kraków 15
Lancaster 15
Manchester 15
Shanghai 15
Da Nang 14
Johannesburg 14
Phoenix 14
Redwood City 14
Toronto 14
Amsterdam 13
Atlanta 13
Bremen 13
Mexico City 13
Belo Horizonte 12
Rio de Janeiro 12
Hangzhou 11
Monza 11
Mountain View 11
Mumbai 11
Naples 11
Shenyang 11
Fremont 10
Guangzhou 10
Macerata 10
Porto Alegre 10
Roubaix 10
Salvador 10
Vienna 10
Hebei 9
Nanchang 9
San Francisco 9
Totale 5.216
Salva come PNG Salva come JPEG
Nome #
Gut microbial flora, prebiotics, and probiotics in IBD: their current usage and utility 369
Irritable bowel syndrome and nickel allergy: What is the role of the low nickel diet? 227
Propionyl-L-carnitine hydrochloride for treatment of mild to moderate colonic inflammatory bowel diseases 202
13C-octanoic acid breath test to study gastric emptying time 184
Efficacy and Mechanisms of Action of Fecal Microbiota Transplantation in Ulcerative Colitis: Pitfalls and Promises From a First Meta-Analysis 179
Comparison between clinical and radiological evaluation before and after medical therapy in patients with Crohn's disease: new prospective roles of CT enterography 169
Comparison between clinical and radiological evaluation before and after medical therapy in patients with Crohn's disease: new prospective roles of CT enterography 167
Erratum to: Binge Drinking among adolescents is related to the development of Alcohol Use Disorders: results from a Cross-Sectional Study (Scientific Reports, (2018), 8, 1, (12624), 10.1038/s41598-018-29311-y) 156
Comparison of performances of infliximab biosimilars CT-P13 versus SB2 in the treatment of inflammatory bowel diseases: a real-life multicenter, observational study in Italy 155
Binge Drinking among adolescents is related to the development of Alcohol Use Disorders: results from a Cross-Sectional Study 153
Origin of celiac disease: How old are predisposing haplotypes? 152
Tricks for interpreting and making a good report on hydrogen and 13C breath tests 148
Body mass index influences infliximab post-infusion levels and correlates with prospective loss of response to the drug in a cohort of inflammatory bowel disease patients under maintenance therapy with Infliximab 148
Intestinal Permeability and Dysbiosis in Female Patients with Recurrent Cystitis: A Pilot Study 147
Diet-Induced Alterations in Gut Microbiota Composition and Function 147
Circulating hematopoietic stem cells and putative intestinal stem cells in coeliac disease 146
The Microbiota-Gut-Brain Axis: Psychoneuroimmunological Insights 145
Rifaximin for the treatment of diarrhoea-predominant irritable bowel syndrome 143
Intestinal gas production and gastrointestinal symptoms: from pathogenesis to clinical implication 141
Nodular lymphoid hyperplasia: A marker of low-grade inflammation in irritable bowel syndrome? 140
Gut microbial flora, prebiotics and probiotics in IBD: their current usage and utility 139
Role of yeasts in healthy and impaired gut microbiota: the gut mycome 139
Transition from intravenous to subcutaneous biological therapies in inflammatory bowel disease: An online survey of patients 135
Case report: Dupilumab treatment improved type 2 disorders in a patient with IPEX syndrome diagnosis 133
Impact of COVID-19 pandemic on the daily management of biotechnological therapy in inflammatory bowel disease patients: Reorganisational response in a high-volume Italian inflammatory bowel disease centre 126
Gut microbial flora, prebiotics, and probiotics in IBD: their current usage and utility 125
Microparticles produced by activated platelets carry a potent and functionally active angiogenic signal in subjects with crohn’s disease 125
Gastrointestinal motility disorder assessment in systemic sclerosis 123
Effect of a multistrain probiotic on leaky gut in patients with diarrhea-predominant irritable bowel syndrome (IBS-D): a pilot study 122
Pancreatic function assessment 121
Multiparametric Evaluation Predicts Different Mid-Term Outcomes in Crohn's Disease 121
Fibrostenosing Crohn's Disease: Pathogenetic Mechanisms and New Therapeutic Horizons 120
Serial Fecal Microbiota Infusions via Colonoscopy for Active Ulcerative Colitis: A Feasibility, Safety, and Translational Monocentric Italian Study 119
Gut and reproductive tract microbiota adaptation during pregnancy: New insights for pregnancy-related complications and therapy 119
Ecology and Machine Learning-Based Classification Models of Gut Microbiota and Inflammatory Markers May Evaluate the Effects of Probiotic Supplementation in Patients Recently Recovered from COVID-19 118
Impact of SARS-CoV-2 Infection on the Course of Inflammatory Bowel Disease in Patients Treated with Biological Therapeutic Agents: A Case-Control Study. 118
Popular diets and nutritional assessment in the management of irritable bowel syndrome in inflammatory bowel disease: an overview of current evidence 114
Addressing Nutritional Knowledge Gaps in Inflammatory Bowel Disease: A Scoping Review 113
Epidemiology of inflammatory bowel disease in the Republic of San Marino: The “EPIMICI – San Marino” study 113
Histologic Disease Persists beyond Mucosal Healing and Could Predict Reactivation in Ulcerative Colitis 113
Radiomics could predict surgery at 10 years in Crohn's disease 112
Crohn's Disease: Radiological Answers to Clinical Questions and Review of the Literature 112
Gastrointestinal motility disorder assessment in systemic sclerosis 112
Cellular and Molecular Determinants of Biologic Drugs Resistance and Therapeutic Failure in Inflammatory Bowel Disease 110
Eluxadoline for the treatment of diarrhoea-predominant irritable bowel syndrome 110
Factors That Affect Adequacy of Colon Cleansing for Colonoscopy in Hospitalized Patients 109
Cytomegalovirus Infection: An Underrated Target in Inflammatory Bowel Disease Treatment 109
Inflammatory Bowel Diseases and Non-Alcoholic Fatty Liver Disease: Piecing a Complex Puzzle Together 108
Review Article: Green Management of IBD—New Paradigms for an Eco-Friendly Approach 108
Bowel contrast-enhanced ultrasound perfusion imaging in the evaluation of Crohn's disease patients undergoing anti-TNFα therapy 107
Secretome modulation of Caco-2 cell line induced by a multi-strain probiotic 106
Extracellular Vesicles: Novel Potential Therapeutic Agents in Inflammatory Bowel Diseases 105
Impact of the Trophic Effects of the Secretome from a Multistrain Probiotic Preparation on the Intestinal Epithelia 104
Effectiveness and safety of vedolizumab in a matched cohort of elderly and nonelderly patients with inflammatory bowel disease: the IG‐IBD LIVE study 101
THE GUT MICROBIOTA AND IMMUNE SYSTEM RELATIONSHIP IN HUMAN GRAFT-VERSUS-HOST DISEASE 99
Clinical value of alarm features for colorectal cancer: A meta-analysis 96
Clinical value of alarm features for colorectal cancer: A meta-analysis 96
Clinical, Radiological, and Surgical Risk Factors for Endoscopic Anastomotic Recurrence Following Surgery in Crohn's Disease 93
Evaluation of tolerability and major factors affecting the adherence to probiotic therapy in patients with irritable bowel syndrome: a prospective, observational, real-life study 92
PET in inflammatory bowel diseases: a new FAPI era? 91
Gut and reproductive tract microbiota adaptation during pregnancy: New insights for pregnancy-related complications and therapy 90
Bariatric procedures and microbiota: patient selection and outcome prediction 89
The Microbiota-Gut-Brain Axis: Psychoneuroimmunological Insights 87
Vascular complications in hospitalized patients with inflammatory bowel disease and acute gastroenteritis and colitis: A propensity score-matched study 85
SECRETOME MODULATION OF CACO2 CELL LINE INDUCED BY A MULTI-STRAIN PROBIOTIC 83
How to identify patients who are less likely to have metachronous neoplasms after a colon cancer: A predictive model 80
Multimodal dynamic ultrasound approach as predictor of response in patients with Crohn’s disease treated with ustekinumab 79
Gut microbiota during dietary restrictions: New insights in non-communicable diseases 77
Clinical Trial IBD Unit: The Role of the Study Nurse in Conduction of Trials and Patients' Care 76
Factors That Affect Adequacy of Colon Cleansing for Colonoscopy in Hospitalized Patients 76
Nonmedical switch of anti-TNF-α biosimilars has no major clinical, pharmacokinetic and psychological impact on patients with IBD - the SAFER Study 74
Cancer Risk in IBD Patients Treated with JAK Inhibitors: Reassuring Evidence from Trials and Real-World Data 73
Systematic review with meta-analysis: the appropriateness of colonoscopy increases the probability of relevant findings and cancer while reducing unnecessary exams 72
Effectiveness and Safety of Switching from Intravenous to Subcutaneous Vedolizumab Formulation in Inflammatory Bowel Disease Patients in Clinical Remission 72
1L- vs. 4L-Polyethylene glycol for bowel preparation before colonoscopy among inpatients: A propensity score-matching analysis 71
The diagnostic yield of colonoscopy in hospitalized patients. An observational multicenter prospective study 68
Risk factors for gastric cancer: is it time to discard PPIs? 67
Higher adenoma recurrence rate after left- versus right-sided colectomy for colon cancer 66
Onset of ulcerative colitis after thyrotoxicosis: a case report and review of the literature 64
Systematic review with meta-analysis: the appropriateness of colonoscopy increases the probability of relevant findings and cancer while reducing unnecessary exams 63
1L- vs. 4L-Polyethylene glycol for bowel preparation before colonoscopy among inpatients: A propensity score-matching analysis 62
The diagnostic yield of colonoscopy in hospitalized patients. An observational multicenter prospective study 56
Guidance for Fecal Microbiota Transplantation Trials in Ulcerative Colitis: The Second ROME Consensus Conference 29
European Consensus on Malabsorption-UEG & SIGE, LGA, SPG, SRGH, CGS, ESPCG, EAGEN, ESPEN, and ESPGHAN. Part 1: Definitions, Clinical Phenotypes, and Diagnostic Testing for Malabsorption 28
European Consensus on Malabsorption-UEG & SIGE, LGA, SPG, SRGH, CGS, ESPCG, EAGEN, ESPEN, and ESPGHAN: Part 2: Screening, Special Populations, Nutritional Goals, Supportive Care, Primary Care Perspective 23
Totale 9.664
Salva come PNG Salva come JPEG
Categoria #
all - tutte 38.451
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 38.451
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202181 0 0 0 0 0 0 0 0 0 16 57 8
2021/2022364 15 25 5 14 22 16 6 71 14 51 56 69
2022/2023930 108 126 79 136 58 101 55 79 93 36 40 19
2023/2024728 25 125 51 46 42 108 50 19 46 34 82 100
2024/20251.843 27 42 147 52 139 63 116 78 181 238 422 338
2025/20264.291 615 195 330 578 737 253 687 235 347 314 0 0
Totale 9.664